ישראל - עברית - Ministry of Health

astellas pharma international b.v., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 100 mg - bendamustine

ישראל - עברית - Ministry of Health

dor pharmaceutical services ltd., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 25 mg/vial - bendamustine

ישראל - עברית - Ministry of Health

astellas pharma international b.v., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 25 mg - bendamustine

ישראל - עברית - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 500 mg/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi

ישראל - עברית - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 1 g/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - dacarbazine as citrate - אבקה להמסה להזרקה\אינפוזיה - dacarbazine as citrate 200 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - dacarbazine as citrate - אבקה להמסה להזרקה\אינפוזיה - dacarbazine as citrate 500 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - dacarbazine as citrate - אבקה להמסה להזרקה\אינפוזיה - dacarbazine as citrate 1000 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - vincristine sulfate - תמיסה להזרקה - vincristine sulfate 1 mg/ml - vincristine - vincristine - vincristine may be used either as sole agent or in combination therapy in the treatment of acute leukemias. malignant lymphomas including hodgkin's disease lymphosarcoma and reticulum cell sarcoma, neuroblastoma, wilm's tumor, rhabdomyosarcoma.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - doxorubicin hydrochloride 10 mg / 5 ml - solution for injection - doxorubicin - adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, hodgkin's lymphomas, neuroblastomas, wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia